Chronic Spontaneous Urticaria: Bringing It Back Where It Belongs – A Disease State Update
At the 2026 ODAC Dermatology Conference, we had the privilege of learning about chronic spontaneous urticaria (CSU) from Dr. Adam Friedman, MD, FAAD, Professor and Chair of Dermatology at The George Washington University School of Medicine. CSU can be a maddening, exhausting condition for patients, with a relapsing disease course and without identifiable triggers. Given that symptoms are often abs …
At the 2026 ODAC Dermatology Conference, we had the privilege of learning about chronic spontaneous urticaria (CSU) from Dr. Adam Friedman, MD, FAAD, Professor and Chair of Dermatology at The George Washington University School of Medicine. CSU can be a maddening, exhausting condition for patients, with a relapsing disease course and without identifiable triggers. Given that symptoms are often abs … 
A 35-year-old female presents to dermatology clinic for the pictured rash, which has been recurring at least once per week for the past six months. Which of the following treatment options works by reducing mast cell degranulation through Bruton tyrosine kinase inhibition?
A. Dupilumab
B. Benralizumab
C. Cromolyn sodium
D. … 
Dermatologists need to be more visible in treating chronic spontaneous urticaria (CSU), says Dr. Adam Friedman, co-chair of the ODAC Dermatology, Aesthetic & Surgical Conference. Next Steps in Derm, in partnership with ODAC, interviewed Dr. Friedman, who shared what to consider when approaching a hive or hive-like patient. Hear the burden that patients with CSU face. Find out the first-line tr … 
Introducing the April 2024 Editorial Highlights from the Journal of Drugs in Dermatology! This month's issue is packed with groundbreaking research and insights into dermatologic treatments and practices. From original articles exploring innovative therapies for conditions like photoaging and acne vulgaris to case reports shedding light on rare dermatologic phenomena, this issue offers a comprehen …